Fractionated administration of irinotecan and cisplatin for treatment of non-small-cell lung cancer: a phase II study of Okayama Lung Cancer Study Group

A phase II study of fractionated administration of irinotecan (CPT-11) and cisplatin (CDDP) in patients with non-small-cell lung cancer (NSCLC) was conducted. Between January 1996 and January 1998, 44 previously untreated patients with stage IIIB or IV NSCLC were enrolled. CDDP at a dose of 60 mg m(...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ueoka, H, Tanimoto, M, Kiura, K, Tabata, M, Takigawa, N, Segawa, Y, Takata, I, Eguchi, K, Okimoto, N, Harita, S, Kamei, H, Shibayama, T, Watanabe, Y, Hiraki, S, Harada, M
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2001
Assuntos:
Regular Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2363923/
https://ncbi.nlm.nih.gov/pubmed/11437395
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2001.1861
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados